Iceland· IS-IS/1/22/068/01
Zamisept
A hexamidine product containing hexamidinum inn diisetionate, registered in Iceland by Laboratoires THEA*. The same ATC class is registered in 8 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Hexamidine is registered in 8 of 19 countries.
Countries holding a registration under ATC S01AX08 (hexamidine), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Hexamidine · ATC S01AX08
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- hexamidinum INN diisetionate
- Manufacturer
- Laboratoires THEA*
- Country
- Iceland (IS)
- ATC code
- S01AX08
- ATC class
- Hexamidine
- Defined daily dose
- 0.1 mg, AT
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01AX08
Hexamidine, as other registers publish it.
- SwitzerlandDesomedin
- SwitzerlandDesomedin, Augentropfen, LösungBausch & Lomb Swiss AG
- SwitzerlandDesomedin, Augentropfen, LösungBausch & Lomb Swiss AG
- BelgiumDesomedine 0.1 %Bausch + Lomb Ireland
- BelgiumDesomedine 0.1 %Bausch & Lomb Pharma
- United KingdomDesomedine 0.1% eye dropsImported (France)
- BelgiumOphtamedine 1 mg/mlLaboratoires Théa
- PolandZamidineLaboratoires Thea
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1f38a157-7154-4ad9-b277-27f696af8ab2 GET /v1/drugs/1f38a157-7154-4ad9-b277-27f696af8ab2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Augndropar, lausn",
"source": "lyfjastofnun",
"atc_raw": "S01AX08",
"marketed": false,
"strength": "1 mg/ml",
"ma_number": "IS/1/22/068/01",
"substance": "hexamidinum INN diisetionate",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "44817"
}See everything about hexamidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.